Definitive Healthcare (DH)
(Delayed Data from NSDQ)
$5.62 USD
-0.03 (-0.53%)
Updated Jul 19, 2024 04:00 PM ET
After-Market: $5.61 -0.01 (-0.18%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth F Momentum B VGM
Definitive Healthcare Corp. (DH) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$8.65 | $10.00 | $7.00 | 53.10% |
Price Target
Based on short-term price targets offered by 10 analysts, the average price target for Definitive Healthcare Corp. comes to $8.65. The forecasts range from a low of $7.00 to a high of $10.00. The average price target represents an increase of 53.1% from the last closing price of $5.65.
Analyst Price Targets (10)
Broker Rating
Definitive Healthcare Corp. currently has an average brokerage recommendation (ABR) of 2.38 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 13 brokerage firms. The current ABR compares to an ABR of 2.38 a month ago based on 13 recommendations.
Of the 13 recommendations deriving the current ABR, four are Strong Buy, representing 30.77% of all recommendations. A month ago, Strong Buy represented 30.77%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/DH.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 4 | 4 | 4 | 4 | 4 |
Buy | 0 | 0 | 0 | 0 | 1 |
Hold | 9 | 9 | 9 | 9 | 8 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.38 | 2.38 | 2.38 | 2.38 | 2.27 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
5/13/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
5/8/2024 | Needham & Company | Ryan Macdonald | Hold | Hold |
5/7/2024 | William Blair | Ryan S Daniels | Strong Buy | Strong Buy |
5/7/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
3/29/2024 | Goldman Sachs | Kasthuri G Rangan | Hold | Hold |
3/1/2024 | Not Identified | Not Identified | Hold | Hold |
2/29/2024 | Canaccord Genuity | David E Hynes | Hold | Hold |
2/28/2024 | Not Identified | Not Identified | Hold | Hold |
2/16/2024 | Robert W. Baird & Co. | Joe Vruwink | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.38 |
ABR (Last week) | 2.38 |
# of Recs in ABR | 13 |
Average Target Price | $8.65 |
LT Growth Rate | 13.60% |
Industry | Medical Info Systems |
Industry Rank by ABR | 74 of 252 |
Current Quarter EPS Est: | 0.09 |